argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
901.17
-14.80 (-1.62%)
At close: Dec 5, 2025, 4:00 PM EST
902.00
+0.83 (0.09%)
After-hours: Dec 5, 2025, 7:19 PM EST
argenx SE Market Cap
argenx SE has a market cap or net worth of $54.89 billion as of December 5, 2025. Its market cap has increased by 61.65% in one year.
Market Cap
54.89B
Enterprise Value
51.04B
1-Year Change
61.65%
Ranking
Category
Stock Price
$901.17
Market Cap Chart
Since May 18, 2017, argenx SE's market cap has increased from $618.00M to $54.89B, an increase of 8,782.19%. That is a compound annual growth rate of 68.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 55.91B | 52.02% |
| Dec 31, 2024 | 36.77B | 72.75% |
| Dec 29, 2023 | 21.29B | 2.05% |
| Dec 30, 2022 | 20.86B | 15.89% |
| Dec 31, 2021 | 18.00B | 29.92% |
| Dec 31, 2020 | 13.85B | 126.49% |
| Dec 31, 2019 | 6.12B | 96.21% |
| Dec 31, 2018 | 3.12B | 83.75% |
| Dec 29, 2017 | 1.70B | 174.53% |
| May 18, 2017 | 618.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |